The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)

Objective: The aim of this study was to determine the prevalence of anabolic androgenic steroid (AAS) use among athletes and examine the extent of their knowledge on the effects of AAS in Riyadh, Saudi Arabia. Methods: This cross-sectional study was conducted at gyms in Riyadh, Saudi Arabia, durin...

Full description

Bibliographic Details
Main Authors: Mosleh Jabari, Hassan Al-shehri, Abdullah Al-faris, Mohammed Al-sayed, Fahd Algaeed, Nasser Al-sobaie, Fawaz Al-saleh
Format: Article
Language:English
Published: Electronic Physician 2016-12-01
Series:Electronic Physician
Subjects:
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279964/
_version_ 1819070792724381696
author Mosleh Jabari
Hassan Al-shehri
Abdullah Al-faris
Mohammed Al-sayed
Fahd Algaeed
Nasser Al-sobaie
Fawaz Al-saleh
author_facet Mosleh Jabari
Hassan Al-shehri
Abdullah Al-faris
Mohammed Al-sayed
Fahd Algaeed
Nasser Al-sobaie
Fawaz Al-saleh
author_sort Mosleh Jabari
collection DOAJ
description Objective: The aim of this study was to determine the prevalence of anabolic androgenic steroid (AAS) use among athletes and examine the extent of their knowledge on the effects of AAS in Riyadh, Saudi Arabia. Methods: This cross-sectional study was conducted at gyms in Riyadh, Saudi Arabia, during 2015. In total 600 athletes from three gyms participated in the study. The study included Saudi and non-Saudi athletes chosen by the simple random sampling method. A self-reported questionnaire was used for data collection. The questionnaire was designed to study the prevalence and assess the knowledge of athletes regarding AAS use. Frequency and percentage distributions were used to describe the data. Comparison between the subgroups was made with a chi- square test. Results: The percentage of AAS users was 30.5%. The age of AAS users ranged from 15 to 49 years with the majority (52.5%) belonging to age group of 25-29 years. Approximately 20% of the users admitted using AAS due to body dysmorphia as their best motivational factor; in addition, they also believed that there are no side effects of the use. Among the nonusers, 40% had appropriate knowledge, while all the AAS-users had inadequate knowledge about the adverse effects of AAS. Moreover, 77% of the users would recommend AAS to their friends but none from the nonusers. A significant difference in age distribution (df = 5, p<0.001) and knowledge (df = 4, p< 0.001) between users and nonusers was observed. Conclusion: Most athletes were ignorant of the harmful side effects of the drug but still continued to use and promote it to other athletes. These athletes should intensify their knowledge and awareness regarding the use of AAS and its effects on the body.
first_indexed 2024-12-21T17:11:34Z
format Article
id doaj.art-eb5fb2cf1bfd4944a9d87d75875409f9
institution Directory Open Access Journal
issn 2008-5842
2008-5842
language English
last_indexed 2024-12-21T17:11:34Z
publishDate 2016-12-01
publisher Electronic Physician
record_format Article
series Electronic Physician
spelling doaj.art-eb5fb2cf1bfd4944a9d87d75875409f92022-12-21T18:56:24ZengElectronic PhysicianElectronic Physician2008-58422008-58422016-12-018123343334710.19082/3343The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)Mosleh JabariHassan Al-shehriAbdullah Al-farisMohammed Al-sayedFahd AlgaeedNasser Al-sobaieFawaz Al-salehObjective: The aim of this study was to determine the prevalence of anabolic androgenic steroid (AAS) use among athletes and examine the extent of their knowledge on the effects of AAS in Riyadh, Saudi Arabia. Methods: This cross-sectional study was conducted at gyms in Riyadh, Saudi Arabia, during 2015. In total 600 athletes from three gyms participated in the study. The study included Saudi and non-Saudi athletes chosen by the simple random sampling method. A self-reported questionnaire was used for data collection. The questionnaire was designed to study the prevalence and assess the knowledge of athletes regarding AAS use. Frequency and percentage distributions were used to describe the data. Comparison between the subgroups was made with a chi- square test. Results: The percentage of AAS users was 30.5%. The age of AAS users ranged from 15 to 49 years with the majority (52.5%) belonging to age group of 25-29 years. Approximately 20% of the users admitted using AAS due to body dysmorphia as their best motivational factor; in addition, they also believed that there are no side effects of the use. Among the nonusers, 40% had appropriate knowledge, while all the AAS-users had inadequate knowledge about the adverse effects of AAS. Moreover, 77% of the users would recommend AAS to their friends but none from the nonusers. A significant difference in age distribution (df = 5, p<0.001) and knowledge (df = 4, p< 0.001) between users and nonusers was observed. Conclusion: Most athletes were ignorant of the harmful side effects of the drug but still continued to use and promote it to other athletes. These athletes should intensify their knowledge and awareness regarding the use of AAS and its effects on the body.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279964/Anabolic androgenic steroidBody dysmorphiaAthletes
spellingShingle Mosleh Jabari
Hassan Al-shehri
Abdullah Al-faris
Mohammed Al-sayed
Fahd Algaeed
Nasser Al-sobaie
Fawaz Al-saleh
The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
Electronic Physician
Anabolic androgenic steroid
Body dysmorphia
Athletes
title The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_full The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_fullStr The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_full_unstemmed The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_short The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_sort prevalence of anabolic androgenic steroid use amongst athletes in riyadh saudi arabia
topic Anabolic androgenic steroid
Body dysmorphia
Athletes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279964/
work_keys_str_mv AT moslehjabari theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT hassanalshehri theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT abdullahalfaris theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT mohammedalsayed theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT fahdalgaeed theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT nasseralsobaie theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT fawazalsaleh theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT moslehjabari prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT hassanalshehri prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT abdullahalfaris prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT mohammedalsayed prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT fahdalgaeed prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT nasseralsobaie prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT fawazalsaleh prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia